• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

果胶通过延缓肠道菌群多样性的丧失来增强粪便微生物群移植在溃疡性结肠炎中的效果。

Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora.

作者信息

Wei Yao, Gong Jianfeng, Zhu Weiming, Tian Hongliang, Ding Chao, Gu Lili, Li Ning, Li Jieshou

机构信息

Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, 21002, China.

出版信息

BMC Microbiol. 2016 Nov 3;16(1):255. doi: 10.1186/s12866-016-0869-2.

DOI:10.1186/s12866-016-0869-2
PMID:27809778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5095982/
Abstract

BACKGROUND

Fecal microbiota transplantation (FMT) induces remission in ulcerative colitis (UC). However, the treatment effect of FMT diminishes over time. Maintaining the diversity of the gut flora for long periods may improve the effects of FMT in UC. Pectin, which can be fermented by gut microbiota into short-chain fatty acids, is postulated to shape the composition and maintain the balance of gut microbiota following transplantation. This study investigated whether pectin could enhance the effects of FMT in UC patients.

RESULTS

Three FMT patients and four FMTP patients achieved the primary outcome. The Mayo scores of the FMTP group were lower than those of the FMT group at weeks 4 and 12 (P = 0.042 and P = 0.042, respectively). There were no differences in the diversity of the gut flora between the two groups at weeks 4 and 12; however, the composition of the gut flora of the FMTP group was more similar than the FMT group to that of the donor at all-time points post-treatment.

CONCLUSIONS

Pectin decreased the Mayo score by preserving the diversity of the gut flora following FMT for UC.

TRIAL REGISTRATION

Current Controlled Trial NCT02016469 . Registered 10 November 2013.

摘要

背景

粪便微生物群移植(FMT)可诱导溃疡性结肠炎(UC)缓解。然而,FMT的治疗效果会随着时间推移而减弱。长期维持肠道菌群的多样性可能会提高FMT对UC的治疗效果。果胶可被肠道微生物群发酵成短链脂肪酸,据推测,它在移植后可塑造肠道微生物群的组成并维持其平衡。本研究调查了果胶是否能增强FMT对UC患者的治疗效果。

结果

3例接受FMT的患者和4例接受FMT联合果胶(FMTP)的患者达到了主要结局。在第4周和第12周时,FMTP组的梅奥评分低于FMT组(分别为P = 0.042和P = 0.042)。在第4周和第12周时,两组肠道菌群的多样性无差异;然而,在治疗后的所有时间点,FMTP组肠道菌群的组成比FMT组更接近供体。

结论

果胶通过在UC患者接受FMT后维持肠道菌群的多样性降低了梅奥评分。

试验注册

当前受控试验NCT02016469。于2013年11月10日注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3861/5095982/0fed294c46ec/12866_2016_869_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3861/5095982/309df6664d05/12866_2016_869_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3861/5095982/27e6e909c6ad/12866_2016_869_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3861/5095982/44ea15b5f2fb/12866_2016_869_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3861/5095982/0fed294c46ec/12866_2016_869_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3861/5095982/309df6664d05/12866_2016_869_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3861/5095982/27e6e909c6ad/12866_2016_869_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3861/5095982/44ea15b5f2fb/12866_2016_869_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3861/5095982/0fed294c46ec/12866_2016_869_Fig4_HTML.jpg

相似文献

1
Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora.果胶通过延缓肠道菌群多样性的丧失来增强粪便微生物群移植在溃疡性结肠炎中的效果。
BMC Microbiol. 2016 Nov 3;16(1):255. doi: 10.1186/s12866-016-0869-2.
2
Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study.单一致病菌移植治疗复发性活动期溃疡性结肠炎的长期疗效和安全性:一项前瞻性随机试验研究。
Microb Cell Fact. 2021 Jan 19;20(1):18. doi: 10.1186/s12934-021-01513-6.
3
Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.单次粪便微生物群移植治疗日本轻至中度活动性溃疡性结肠炎患者的疗效和安全性。
J Gastroenterol. 2017 Apr;52(4):476-482. doi: 10.1007/s00535-016-1271-4. Epub 2016 Oct 11.
4
Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes.粪便微生物群移植治疗溃疡性结肠炎:最佳时机和肠道微生物群作为长期临床结局的预测因素。
Clin Transl Gastroenterol. 2020 Aug;11(8):e00224. doi: 10.14309/ctg.0000000000000224.
5
Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.粪便微生物移植对溃疡性结肠炎患者 8 周缓解的影响:一项随机临床试验。
JAMA. 2019 Jan 15;321(2):156-164. doi: 10.1001/jama.2018.20046.
6
Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.通过结肠镜单次递送高多样性粪便微生物群制剂对增加活动性溃疡性结肠炎的微生物多样性是安全有效的。
Inflamm Bowel Dis. 2017 Jun;23(6):903-911. doi: 10.1097/MIB.0000000000001132.
7
Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis.逐步增加的粪便微生物群移植策略:一项针对类固醇依赖型溃疡性结肠炎的试点研究。
J Transl Med. 2015 Sep 12;13:298. doi: 10.1186/s12967-015-0646-2.
8
Fecal Microbiota Transplantation in Experimental Ulcerative Colitis Reveals Associated Gut Microbial and Host Metabolic Reprogramming.粪便微生物移植在实验性溃疡性结肠炎中的作用揭示了相关的肠道微生物和宿主代谢重编程。
Appl Environ Microbiol. 2018 Jul 2;84(14). doi: 10.1128/AEM.00434-18. Print 2018 Jul 15.
9
Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.复发性艰难梭菌感染和/或溃疡性结肠炎患者单次供体粪便微生物群移植的纵向微生物组分析
PLoS One. 2018 Jan 31;13(1):e0190997. doi: 10.1371/journal.pone.0190997. eCollection 2018.
10
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.粪便微生物群移植在随机对照试验中诱导活动期溃疡性结肠炎患者缓解。
Gastroenterology. 2015 Jul;149(1):102-109.e6. doi: 10.1053/j.gastro.2015.04.001. Epub 2015 Apr 7.

引用本文的文献

1
Fecal microbiota transplantation: application scenarios, efficacy prediction, and factors impacting donor-recipient interplay.粪便微生物群移植:应用场景、疗效预测及影响供体-受体相互作用的因素
Front Microbiol. 2025 Mar 25;16:1556827. doi: 10.3389/fmicb.2025.1556827. eCollection 2025.
2
Prebiotic selection influencing inflammatory bowel disease treatment outcomes: a review of the preclinical and clinical evidence.影响炎症性肠病治疗结果的益生元选择:临床前和临床证据综述
eGastroenterology. 2024 Apr 3;2(2):e100055. doi: 10.1136/egastro-2023-100055. eCollection 2024 Apr.
3
Deciphering Pectin: A Comprehensive Overview of Its Origins, Processing, and Promising Utility.

本文引用的文献

1
Fecal transplantation - the new, inexpensive, safe, and rapidly effective approach in the treatment of gastrointestinal tract diseases.粪便移植——治疗胃肠道疾病的新型、廉价、安全且快速有效的方法。
J Med Life. 2016 Apr-Jun;9(2):160-2.
2
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.粪便微生物群移植在随机对照试验中诱导活动期溃疡性结肠炎患者缓解。
Gastroenterology. 2015 Jul;149(1):102-109.e6. doi: 10.1053/j.gastro.2015.04.001. Epub 2015 Apr 7.
3
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.
解读果胶:对其起源、加工及潜在用途的全面概述
ACS Omega. 2024 Dec 20;10(1):1-15. doi: 10.1021/acsomega.4c01843. eCollection 2025 Jan 14.
4
Global and regional genetic association analysis of ulcerative colitis and type 2 diabetes mellitus and causal validation analysis of two-sample two-way Mendelian randomization.溃疡性结肠炎和2型糖尿病的全球及区域遗传关联分析以及两样本双向孟德尔随机化的因果验证分析
Front Immunol. 2024 Nov 22;15:1375915. doi: 10.3389/fimmu.2024.1375915. eCollection 2024.
5
Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome.粪便(或肠道)微生物群移植:修复肠道微生物组的工具。
Gut Microbes. 2024 Jan-Dec;16(1):2423026. doi: 10.1080/19490976.2024.2423026. Epub 2024 Nov 5.
6
Therapeutic and Immunologic Effects of Short-Chain Fatty Acids in Inflammatory Bowel Disease: A Systematic Review.短链脂肪酸在炎症性肠病中的治疗和免疫效应:系统评价。
Int J Mol Sci. 2024 Oct 10;25(20):10879. doi: 10.3390/ijms252010879.
7
The Role of Fecal Microbiota Transplantation in IBD.粪便微生物群移植在炎症性肠病中的作用
Microorganisms. 2024 Aug 23;12(9):1755. doi: 10.3390/microorganisms12091755.
8
Hot topics on fecal microbiota transplantation for the treatment of inflammatory bowel disease.粪便微生物群移植治疗炎症性肠病的热点话题。
Front Med (Lausanne). 2022 Dec 2;9:1068567. doi: 10.3389/fmed.2022.1068567. eCollection 2022.
9
Pre-Antibiotic Treatment Followed by Prolonged Repeated Faecal Microbiota Transplantation Improves Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: An Observational Australian Clinical Experience.抗生素治疗前进行长期反复的粪便微生物群移植可改善肠易激综合征患者的症状和生活质量:一项澳大利亚观察性临床经验。
Gastroenterol Res Pract. 2022 Oct 13;2022:6083896. doi: 10.1155/2022/6083896. eCollection 2022.
10
Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: A systematic review and meta-analysis.粪便微生物群移植治疗自身免疫性疾病和自身炎症性疾病的安全性和有效性:系统评价和荟萃分析。
Front Immunol. 2022 Sep 30;13:944387. doi: 10.3389/fimmu.2022.944387. eCollection 2022.
粪便移植治疗溃疡性结肠炎的随机对照试验结果。
Gastroenterology. 2015 Jul;149(1):110-118.e4. doi: 10.1053/j.gastro.2015.03.045. Epub 2015 Mar 30.
4
Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis.Gpr109a 的激活,作为烟酸和共生代谢物丁酸盐的受体,可抑制结肠炎症和癌变。
Immunity. 2014 Jan 16;40(1):128-39. doi: 10.1016/j.immuni.2013.12.007. Epub 2014 Jan 9.
5
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.共生菌产生的代谢物可促进外周调节性 T 细胞的生成。
Nature. 2013 Dec 19;504(7480):451-5. doi: 10.1038/nature12726. Epub 2013 Nov 13.
6
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.共生微生物衍生的丁酸盐诱导结肠调节性 T 细胞的分化。
Nature. 2013 Dec 19;504(7480):446-50. doi: 10.1038/nature12721. Epub 2013 Nov 13.
7
Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis.粪菌移植改变肠道菌群失调并不能诱导慢性活动性溃疡性结肠炎患者缓解。
Inflamm Bowel Dis. 2013 Sep;19(10):2155-65. doi: 10.1097/MIB.0b013e31829ea325.
8
The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis.微生物代谢产物,短链脂肪酸,调节结肠 Treg 细胞稳态。
Science. 2013 Aug 2;341(6145):569-73. doi: 10.1126/science.1241165. Epub 2013 Jul 4.
9
Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis.粪便移植治疗儿童和青年溃疡性结肠炎的安全性、耐受性和临床应答。
J Pediatr Gastroenterol Nutr. 2013 Jun;56(6):597-601. doi: 10.1097/MPG.0b013e318292fa0d.
10
Duodenal infusion of donor feces for recurrent Clostridium difficile.经十二指肠输注供体粪便治疗复发性艰难梭菌感染。
N Engl J Med. 2013 Jan 31;368(5):407-15. doi: 10.1056/NEJMoa1205037. Epub 2013 Jan 16.